Figure 2 — Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer’s disease

Research Paper|Volume 13, Issue 20|pp. 23739–23756

Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer’s disease

Back to articleFigure 2(2 of 8)

100%

Figure 2.Effects of loganin on AD pathology and the expression of Aβ-related key proteins. (A) The relative expression of Aβ deposition. (B, C) The relative expression of APP expression and processing related proteins. (D) The relative expression of Tau phosphorylation. Scale bar = 100 μm. Data were expressed as mean ± SEM, ^*p < 0.05, ^***p < 0.001, n = 3 for each group.